WO1999053777A1 - Complement nutritionnel pour femmes enceintes et allaitantes - Google Patents
Complement nutritionnel pour femmes enceintes et allaitantes Download PDFInfo
- Publication number
- WO1999053777A1 WO1999053777A1 PCT/EP1999/002668 EP9902668W WO9953777A1 WO 1999053777 A1 WO1999053777 A1 WO 1999053777A1 EP 9902668 W EP9902668 W EP 9902668W WO 9953777 A1 WO9953777 A1 WO 9953777A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particularly preferred
- vitamin
- protein
- milk
- fibre
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims description 7
- 239000000203 mixture Substances 0.000 claims abstract description 66
- 235000013336 milk Nutrition 0.000 claims abstract description 24
- 239000008267 milk Substances 0.000 claims abstract description 24
- 210000004080 milk Anatomy 0.000 claims abstract description 24
- 229940088594 vitamin Drugs 0.000 claims abstract description 22
- 229930003231 vitamin Natural products 0.000 claims abstract description 22
- 235000013343 vitamin Nutrition 0.000 claims abstract description 22
- 239000011782 vitamin Substances 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 16
- 239000011707 mineral Substances 0.000 claims abstract description 16
- 235000010755 mineral Nutrition 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 235000016709 nutrition Nutrition 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 12
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 8
- 235000018102 proteins Nutrition 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 11
- 235000020774 essential nutrients Nutrition 0.000 claims description 11
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 10
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 241000209140 Triticum Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229920001542 oligosaccharide Polymers 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
- 108010073771 Soybean Proteins Proteins 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 5
- 235000013734 beta-carotene Nutrition 0.000 claims description 5
- 239000011648 beta-carotene Substances 0.000 claims description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 5
- 229960002747 betacarotene Drugs 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 239000011669 selenium Substances 0.000 claims description 5
- 229910052711 selenium Inorganic materials 0.000 claims description 5
- 235000011649 selenium Nutrition 0.000 claims description 5
- 229940001941 soy protein Drugs 0.000 claims description 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 5
- 235000005282 vitamin D3 Nutrition 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- 229940021056 vitamin d3 Drugs 0.000 claims description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- -1 manganese, vitamin K Chemical class 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 235000016804 zinc Nutrition 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- 108010084695 Pea Proteins Proteins 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 235000019702 pea protein Nutrition 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 235000007686 potassium Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 240000002791 Brassica napus Species 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 2
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 2
- 235000008696 isoflavones Nutrition 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 3
- 239000008101 lactose Substances 0.000 abstract description 3
- 229920002774 Maltodextrin Polymers 0.000 description 10
- 239000005913 Maltodextrin Substances 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 235000010469 Glycine max Nutrition 0.000 description 8
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 5
- 230000006651 lactation Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- 201000010538 Lactose Intolerance Diseases 0.000 description 3
- 240000008790 Musa x paradisiaca Species 0.000 description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 3
- 235000019486 Sunflower oil Nutrition 0.000 description 3
- 244000290333 Vanilla fragrans Species 0.000 description 3
- 235000009499 Vanilla fragrans Nutrition 0.000 description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 229960003284 iron Drugs 0.000 description 3
- 239000008347 soybean phospholipid Substances 0.000 description 3
- 239000002600 sunflower oil Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 3
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000012182 cereal bars Nutrition 0.000 description 2
- 229940108928 copper Drugs 0.000 description 2
- 229940108925 copper gluconate Drugs 0.000 description 2
- 235000012777 crisp bread Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229960004903 invert sugar Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000019895 oat fiber Nutrition 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- FPRKGXIOSIUDSE-SYACGTDESA-N (2z,4z,6z,8z)-docosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCCC\C=C/C=C\C=C/C=C\C(O)=O FPRKGXIOSIUDSE-SYACGTDESA-N 0.000 description 1
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 235000021292 Docosatetraenoic acid Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000005569 Iron sulphate Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical group [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 102000002419 Motilin Human genes 0.000 description 1
- 101800002372 Motilin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229940106635 calcium amino acid chelate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- AVWJKAIFMUEKMH-UHFFFAOYSA-L calcium hydrogen phosphate phosphoric acid Chemical compound [Ca+2].OP(O)(O)=O.OP(O)(O)=O.OP([O-])([O-])=O AVWJKAIFMUEKMH-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910000394 calcium triphosphate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000008370 chocolate flavor Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000008410 fruit bars Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000021416 maternal diet Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003988 neural development Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000009696 proliferative response Effects 0.000 description 1
- 235000011890 sandwich Nutrition 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000011270 sweet biscuits Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229940015977 teferrol Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- This invention provides a nutritional composition for pregnant and lactating women and food products or dietary supplements comprising said composition.
- Constipation is common in pregnancy. This is thought to be related to the increase in circulating progesterone and possibly decreased levels of motilin. Dietary fibre has a major effect on colonic function and is a safe means to relieve pregnant women of their constipation.
- Calcium is among the nutrients the recommended levels of which is increased proportionately more than that of energy and the other nutrients during pregnancy and lactation and taking extra milk or dairy products will normally provide additional calcium. - 2 -
- lactose intolerant individuals need an alternative calcium source which contains no lactose. Lactose- intolerance is one of the major reasons for milk intolerance. Furthermore, it is known that exposure of the foetus via the placenta to cow's milk can result in primary sensitisation to cow's milk allergens, leading to positive proliferative responses when the infant is exposed to cow's milk after birth.
- the present invention therefore, provides a nutritional composition for pregnant and lactating women comprising: a non-milk-derived protein source, a dietary fibre and/or fibre-like substance, a source of polyunsaturated fatty acids, minerals and vitamins recommended for pregnant and lactating women, characterized in that the composition is lactose-free and contains less than 2 % of milk or milk-derived products by weight of dry components of the composition.
- the composition according to the invention contains less than 1.5 weight % (more preferred less than 1 weight%) by weight of dry components of the composition of milk or milk-derived products such as caseinates, particularly preferred the composition is milk-free, i.e. it contains no detectable levels of milk or milk-derived products. Lactose-free as used herein means that the composition contains no detectable lactose.
- composition according to the invention comprises the following minerals and vitamins recommended for pregnant and lactating women: calcium, magnesium, iron, copper, zinc, iodine, vitamin A, vitamin E, vitamin B 1 f vitamin B 2 , vitamin B 6 , vitamin B ⁇ 2 , vitamin C, folic acid, niacin. - 3 -
- composition of the invention preferably comprises the following daily amounts of essential nutrients:
- dietary fibre and/or fibre-like substance preferably 4 to 6 g, particularly preferred 5 g, of polyunsaturated fatty acids
- 1 g to 30 g of linoleic acid preferably 2.0 to 5.0 g, particularly preferred 3.0 g, 0.1 mg to 3.6 g calcium, preferably 320 to 530 mg, particularly preferred 400 mg, 0.1 mg to 1.1 g magnesium, preferably 60 to 90 mg, particularly preferred 75 mg, 0.01 mg to 90 mg iron, preferably 8 to 12 mg, particularly preferred 10 mg, 0.01 mg to 60 mg zinc, preferably 4 to 6 mg, particularly preferred 5 mg, 0.01 mg to 3 mg copper, preferably 0.1 to 0.4 mg, particularly preferred 0.25 mg, 0.01 mg to 0.6 mg iodine, preferably 24 to 36 ⁇ g, particularly preferred 30 ⁇ g, 0.01 mg to 4.0 mg vitamin A, preferably 80 to 120 ⁇ g, particularly preferred 100 ⁇ g, 0.01 mg to 40 mg vitamin E, preferably 2.4 to 3.6 mg, particularly preferred 3 mg, 0.01 mg to 5 mg vitamin B ⁇ , preferably 0.16 to 0.24 mg, particularly preferred 0.2 mg, 0.01 mg to 6 mg vitamin B 2 ,
- non-milk-derived protein source egg protein, soy protein (particularly soy protein low in isoflavones), soy isolate, pea protein, pea hydrolysate, rice protein, rice hydrolysate, soy hydrolysate, wheat hydrolysate, potato hydrolysate, rapeseed protein, lupin protein, wheat protein and/or wheat isolate.
- the non-milk-derived protein source is soy protein.
- Suitable dietary fibres include insoluble and soluble fibres and mixtures thereof.
- Suitable insoluble fibres include one or more members selected from the following group: cellulose, wheat fibre, soy fibre, pea fibre, oat fibre and beet fibre.
- Suitable soluble fibres include one or more members selected from the following group: pectin, xanthan gum, hydrolysed guar gum and gum arabic.
- Suitable substances with fibre-like activity are inulin and oligosaccharides such as hydrolysed inulin, soy- oligosaccharides, galacto- oligosaccharides, fructo-oligosaccharides and xylo-oligosaccharides.
- Oligosaccharides are prebiotic substances with fibre-like physiological activity, i.e. they have mild laxative effect.
- the composition comprises oligosaccharides and in particular fructo- oligosaccharides and/or xylo-oligosaccharides as fibre-like substances.
- soluble and/or fiber-like substance to insoluble fiber can vary from 9:1 to 2:3, a preferrred weight ratio is about 2-4 part soluble fibers and/or fibre-like substance to about 1 part insoluble fibers.
- DHA docosahexaenoic acid
- DPA docosapentaenoic acid
- EPA eicosapentaenoic acid
- AA arachidonic acid
- DTA Adrenic
- Preferred sources of long chain polyunsaturated fatty acids are fish oil which typically contains 15 to 25% DHA and 5 to 15% EPA as well as sources from microalgae which typically contain 40% DHA. If the long-chain polyunsaturated fatty acid employed is of the precursor-type which still has to be metabolized to the active form in the body such as alpha-linolenic acid or linoleic acid, then the daily amount preferably lies in the range of 0.5 g to 12 g or 1 g to 30 g respectively.
- the daily amount preferably lies in the range of 0.01 ⁇ g (preferably 1.0 ⁇ g) to 2.0 g of long-chain poly-unsaturated fatty acid. - 5 -
- Suitable calcium forms are e.g. calcium phosphate, calcium citrate, calcium carbonate or calcium amino acid chelate.
- Suitable magnesium forms are e.g. magnesium oxide or magnesium sulfate.
- Suitable iron forms are e.g. iron pyrophosphate, iron polymaltose, iron sulphate or iron chelate.
- Suitable zinc forms are e.g. zinc sulphate or zinc lactate.
- Suitable copper forms are e.g. copper gluconate, copper sulphate or copper oxide.
- Suitable iodine forms are e.g. potassium iodide or potassium iodate.
- the nutritional composition further comprises one or more of the following minerals and vitamins: potassium, selenium, manganese, vitamin K, biotin, pantothenic acid, choline, vitamin D3 and beta-carotene.
- Typical daily amounts of these minerals and vitamins are 0.1 mg to 5 g of potassium, 0.1 ⁇ g to 200 ⁇ g of selenium, 0.1 ⁇ g to 500 ⁇ g manganese, 0.1 ⁇ g to 200 ⁇ g vitamin K, 0.1 ⁇ g to 150 ⁇ g biotin, 0.1 ⁇ g to 5 mg panthotenic acid, 0.1 mg to 1 g choline, 0.1 ⁇ g to 30 ⁇ g of vitamin D3 and 0.1 mg to 30 mg of beta- carotene.
- Suitable potassium forms are e.g. potassium citrate or potassium phosphate.
- a suitable selenium form is e.g. selenium yeast.
- a suitable manganese form is e.g. manganese phosphate.
- the nutritional composition preferably further comprises a carbohydrate source. Typically daily amounts of 20 g to 70 g of a carbohydrate source are provided.
- Suitable carbohydrate sources include maltodextrins, malt extract, cereals, fruit flakes, invert sugar, sucrose, fructose, dextrose and glucose, whereby maltodextrin and cereals are preferred. - 6 -
- the nutritional composition may be in the form of a soup or drink such as a powdered cold or hot water instant drink or soup or a ready-to-consume liquid form, in the form of a bar such as. a cereal or fruit bar, in form of a salted or sweet biscuit or in the form of a meal replacement.
- composition of the invention provides the daily amounts of essential nutrients in a single dose unit.
- the nutritional compositions of the present invention can be formulated into food products or dietary supplements.
- the invention also relates to food products comprising the nutritional composition of the invention.
- the term "food product” is intended to cover the whole variety of foods and beverages, including but not limited to powdered instant drinks, baked products such as bread, crisp bread, crisp bread sandwiches, biscuits and cakes, dairy substitute foods, desserts, confectionary products, spreads, cereal and/or fruit bars, breakfast cereals, juices and the like.
- Preferred food formats are powdered instant drinks and cereal bars.
- Preferred as food products are those which are likely to be classified as "functional foods", i.e. foods that are similar in appearance to conventional foods and are intended to be consumed as part of a normal diet or as a supplement, but have been nutritionally tailored to perform physiological roles beyond the provision of simple nutrient requirements.
- the invention also foresees dietary supplements comprising the composition of the invention.
- dietary supplements comprising the composition of the invention.
- the latter are intended for ingestion in pill, capsule, tablet, chewable candies, tabs or liquid form.
- composition of the invention in the manufacture of a food product or dietary supplement for pregnant and lactating women.
- the invention further provides a method for supplementing the extra-needs of essential nutrients of pregnant and lactating women and for treating and/or preventing constipation comprising administering to said pregnant and lactating women effective amounts of - 7 -
- a nutritional composition comprising: a non-milk-derived protein source, a dietary fibre and/or fibre-like substance, a source of polyunsaturated fatty acids, minerals and vitamins recommended for pregnant and lactating women, whereby the composition is lactose-free and contains less than 2 % of milk or milk-derived products by weight of dry components of the composition.
- a powdered cold water instant drink to be reconstituted by 35g powder in 150 ml cold water which has following profile: Recommended daily amount 35g
- soya isolate 34 0% sucrose 18.0% fructo-oligosaccharides 15.6% encapsulated fish oil, BASF 9.6% maltodextrin DE20 8.6% cocoa powder 7.0% mineral mix 4.0% chocolate flavour 1 .5%
- MCT oil is added to the maltodextrin and mixed for 10 minutes in a Carpentier mixer. Then the remaining ingredients are added to the maltodextrin blend and further mixed for 20 minutes.
- Vitamin E acetate 50% 7.4%
- Vitamin D3 1.75%
- Vitamin A acetate 325 0.95%
- soya isolate 12.0 % fructo-oligosaccharides 10.0 % banana flakes 7.5 % sunflower oil 7.5 %
- VM (as in Example 1 ) 0.5 % source of microalgae oil DHASCO, Martek Biosciences Corporation 1.5 % soya lecithin 0.5 % antioxidant vit E 0.01 %
- the glucose syrup and inverted sugar are heated up to 1 10°C.
- the sunflower oil is first warmed separately to 50°C in a tank, then the soya lecithin and antioxidant are added to the sunflower oil and mixed until homogenous.
- the oil blend is added to the syrup mix and mixed in a dough mixer for 10 minutes.
- the microalgal oil is added and further mixed for 5 minutes. All the remaining ingredients are added and further mixed for 10 minutes. Then the mass is rolled out, cooled down to 20°C and formed into bars.
- a powdered cold water/juice instant drink to be reconstituted by 32g powder in 150-200 ml cold water or fruit juice which has following profile: Recommended daily amount 32g
- composition pea protein 19.0% sucrose 32.36% inulin 13.8% encapsulated fish oil, BASF 8.6% maltodextrin DE20 9.6% banana powder 5.0% oat fiber 4.0% calcium lactate, soluble 3.32 banana flavour 1.6%
- maltodextrin DE20 48.664 % iron-lll-pyrophosphate 39.46% selenium yeast 1000 6.5% zinc sulphate 5.35% potassium iodide 0.026%
- Vitamin K powder 5% 0.15%
- Vitamin E acetate 50% 8.3%
- Vitamin A acetate 325 4.8%
- Vitamin B 2 0.42%
- Vitamin B 12 1 % 0.073%
- VM (as in Example 1 ) 0.5% fructo-oligosaccharides 3.0% microalgae oil DHASCO, Martek Biosciences Corporation 1.0% sodium carbonate 0.2% vanilla 0.3% soya lecithin 0.4% antioxidant vit E 0.01 %
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU37094/99A AU3709499A (en) | 1998-04-22 | 1999-04-20 | Nutritional supplement for pregnant and lactating women |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808579.8A GB9808579D0 (en) | 1998-04-22 | 1998-04-22 | Improvements in or relating to organic compounds |
GB9808579.8 | 1998-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999053777A1 true WO1999053777A1 (fr) | 1999-10-28 |
Family
ID=10830788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/002668 WO1999053777A1 (fr) | 1998-04-22 | 1999-04-20 | Complement nutritionnel pour femmes enceintes et allaitantes |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3709499A (fr) |
GB (1) | GB9808579D0 (fr) |
WO (1) | WO1999053777A1 (fr) |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1155620A1 (fr) * | 2000-05-18 | 2001-11-21 | SportsCom Danmark ApS | Composition nutritive comme suppléments diététiques |
WO2001097822A1 (fr) * | 2000-06-20 | 2001-12-27 | Oy Aboatech Ab | Probiotiques pour la prevention primaire de maladies atopiques |
WO2002052954A2 (fr) * | 2001-01-08 | 2002-07-11 | Societe Des Produits Nestle S.A. | Composition nutritionnelle destinee a une pathologie osseuse |
EP1330957A2 (fr) * | 2002-01-15 | 2003-07-30 | Karl-Heinz Bauer | Supplement nutritive |
WO2004091317A1 (fr) * | 2003-04-17 | 2004-10-28 | Boehringer Ingelheim International Gmbh | Supplement multivitamines/mineraux pour femmes enceintes |
WO2005013721A1 (fr) * | 2003-07-15 | 2005-02-17 | Nestec S.A. | Composition nutritionnelle liquide ou en poudre a forte teneur en fibres et en calories |
FR2864426A1 (fr) * | 2003-12-29 | 2005-07-01 | Arandi | Complement alimentaire destine a combler les deficits nutritionnels |
WO2005122791A2 (fr) * | 2004-06-22 | 2005-12-29 | N.V. Nutricia | Amelioration de l'integrite de la barriere intestinale chez les patients atteints de vih |
JP2007215498A (ja) * | 2006-02-17 | 2007-08-30 | Otsuka Pharmaceut Co Ltd | 妊婦用飲料 |
WO2007105945A3 (fr) * | 2006-03-10 | 2007-11-08 | Nutricia Nv | Utilisation de saccharides non digestibles pour assurer à un nouveau-né le meilleur départ dans la vie |
GB2438157A (en) * | 2006-05-18 | 2007-11-21 | Emma Derbyshire | Fortified drink for pregnant or postpartum mothers |
US7560447B2 (en) | 2000-05-08 | 2009-07-14 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
WO2009153065A1 (fr) | 2008-06-19 | 2009-12-23 | N.V. Nutricia | Composition nutritionnelle pour patients de chirurgie bariatrique |
US20120027738A1 (en) * | 2006-05-23 | 2012-02-02 | Nestec S.A. | Maternal supplement |
FR2963725A1 (fr) * | 2010-08-16 | 2012-02-17 | Holymark | Composition alimentaire pour prevenir et limiter la perte de masse musculaire, la perte de densite minerale osseuse et le declin cognitif, en particulier chez les personnes agees de 50 ans et plus |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
CN102640934A (zh) * | 2011-02-18 | 2012-08-22 | 周大捷 | 制备含α-亚麻酸、卵磷脂、维生素E、可溶性膳食纤维素的营养粉的方法 |
US8277836B2 (en) | 1998-08-11 | 2012-10-02 | N.V. Nutricia | Carbohydrates mixture |
EP2508193A1 (fr) * | 2011-04-05 | 2012-10-10 | Nestec S.A. | Utilisation de composition de céréale hypoallergénique pour induire une tolérance orale spécifique |
US8372442B2 (en) | 2008-06-19 | 2013-02-12 | N.V. Nutricia | Liquid nutritional composition for bariatric surgery patients |
EP2597958A1 (fr) | 2010-07-28 | 2013-06-05 | Dawn Foods B.V. | Agent de glaçage pour produits de boulangerie |
WO2014134053A1 (fr) * | 2013-02-26 | 2014-09-04 | Jiva Pharma, Inc. | Esters d'ascorbate d'acides gras oméga 3 |
WO2015089009A1 (fr) * | 2013-12-09 | 2015-06-18 | Abbott Laboratories | Compositions nutritionnelles contenant une protéine de riz conjointement avec des protéines de pois et/ou pomme de terre |
US9084433B2 (en) | 2004-06-06 | 2015-07-21 | N. V. Nutricia | Intestinal barrier integrity |
US20160198748A1 (en) * | 2013-05-28 | 2016-07-14 | Purecircle Sdn Bhd | High-Purity Steviol Glycosides |
EP2403352B1 (fr) * | 2009-03-02 | 2017-03-15 | Roquette Freres | Poudre granulée contenant des protéines végétales et des fibres, leur procédé d'obtention et leurs utilisations |
EP3323296A1 (fr) * | 2016-11-16 | 2018-05-23 | Maresol GmbH & Co. KG | Chocolat avec éléments nutritifs ajoutés et procédé de fabrication d'un chocolat |
US10426791B2 (en) | 2004-05-17 | 2019-10-01 | N.V. Nutricia | Synergism of GOS and polyfructose |
CN111165812A (zh) * | 2020-03-31 | 2020-05-19 | 中国农业大学 | 一种基于豌豆蛋白的针对过敏人群的全营养配方食品 |
CN111480838A (zh) * | 2020-05-26 | 2020-08-04 | 辽宁康汇医学临床研究有限公司 | 一种哺乳期产妇用营养复合粉及其制备方法 |
WO2021005088A1 (fr) * | 2019-07-11 | 2021-01-14 | Société des Produits Nestlé S.A. | Compositions alimentaires pour la gestion du poids |
EP3771342A1 (fr) * | 2019-07-31 | 2021-02-03 | Lactalis Puleva, S.L. | Produit laitier buvable pour femmes enceintes et allaitantes |
CN113133485A (zh) * | 2020-01-17 | 2021-07-20 | 沃正营养(北京)科技有限公司 | 一种乳母营养粉 |
CN113383821A (zh) * | 2021-05-20 | 2021-09-14 | 浙江核力欣健药业有限公司 | 一种产褥期妇女专用营养配方粉及其制备方法 |
US11206841B2 (en) | 2016-09-09 | 2021-12-28 | International Agriculture Group, LLC | Yogurt product from high starch fruits |
US11259551B2 (en) | 2016-09-09 | 2022-03-01 | International Agriculture Group, LLC | Natural cocoa alternative and methods of producing same |
CN114340407A (zh) * | 2019-09-05 | 2022-04-12 | 雀巢产品有限公司 | 用于哺乳女性的食物组合物 |
CN114340406A (zh) * | 2019-09-05 | 2022-04-12 | 雀巢产品有限公司 | 用于哺乳女性的食物组合物 |
CN114340409A (zh) * | 2019-09-05 | 2022-04-12 | 雀巢产品有限公司 | 用于哺乳女性的食物组合物 |
CN114945710A (zh) * | 2019-11-22 | 2022-08-26 | Asa-能源有限公司 | 用于产生气态氢和氧的电解反应系统 |
CN115530381A (zh) * | 2022-08-17 | 2022-12-30 | 中南大学 | 预防产前抑郁症的蛋白粉及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1274665A1 (ru) * | 1984-12-21 | 1986-12-07 | Истринское Отделение Всесоюзного Научно-Исследовательского Института Молочной Промышленности | Способ получени детского безлактозного продукта "фиталакт |
US4737364A (en) * | 1986-02-06 | 1988-04-12 | Kalogris Theodore P | Nutritional dry food concentrate |
EP0705539A2 (fr) * | 1994-10-06 | 1996-04-10 | Friesland Brands B.V. | Produit alimentaire pour femmes enceintes et allaitantes |
-
1998
- 1998-04-22 GB GBGB9808579.8A patent/GB9808579D0/en not_active Ceased
-
1999
- 1999-04-20 AU AU37094/99A patent/AU3709499A/en not_active Abandoned
- 1999-04-20 WO PCT/EP1999/002668 patent/WO1999053777A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1274665A1 (ru) * | 1984-12-21 | 1986-12-07 | Истринское Отделение Всесоюзного Научно-Исследовательского Института Молочной Промышленности | Способ получени детского безлактозного продукта "фиталакт |
US4737364A (en) * | 1986-02-06 | 1988-04-12 | Kalogris Theodore P | Nutritional dry food concentrate |
EP0705539A2 (fr) * | 1994-10-06 | 1996-04-10 | Friesland Brands B.V. | Produit alimentaire pour femmes enceintes et allaitantes |
Non-Patent Citations (4)
Title |
---|
DATABASE CAB [online] CAB INTERNATIONAL, WALLINGFORD, OXON, GB; BUSINCO L: "Prophylaxis of cow's milk allergy.", XP002114127, retrieved from DIALOG Database accession no. 00547049 * |
DATABASE WPI Section Ch Week 8731, Derwent World Patents Index; Class D13, AN 87-219994, XP002114114 * |
DEUTSCHE GESELLSCHAFT FÜR ERNÄHRUNG: "Empfehlungen für die Nährstoffzufuhr", 1991, UMSCHAU VERLAG, GERMANY, XP002114113 * |
H. SCHERZ, F. SENSER: "Food Composition and Nutrition Tables 1989/90", 1989, WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT MBH, STUTTGART, XP002114112 * |
Cited By (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8580295B2 (en) | 1998-08-11 | 2013-11-12 | N.V. Nutricia | Carbohydrates mixture |
US8277836B2 (en) | 1998-08-11 | 2012-10-02 | N.V. Nutricia | Carbohydrates mixture |
US9763466B2 (en) | 1998-08-11 | 2017-09-19 | N.V. Nutricia | Carbohydrates mixture |
US7560447B2 (en) | 2000-05-08 | 2009-07-14 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
US7772217B2 (en) | 2000-05-08 | 2010-08-10 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
US8865687B2 (en) | 2000-05-08 | 2014-10-21 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
US8377912B2 (en) | 2000-05-08 | 2013-02-19 | N. V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
AU2001256142B2 (en) * | 2000-05-18 | 2005-05-26 | Q-Mega Healthcare A/S | A nutritional composition for dietary supplements |
EP1554933A1 (fr) * | 2000-05-18 | 2005-07-20 | SportsCom Danmark ApS | Un comprimé contenant une composition nutritive pour des suppléments diététiques |
WO2001087079A1 (fr) * | 2000-05-18 | 2001-11-22 | Sportscom Danmark Aps | Composition nutritionnelle de supplements dietetiques |
EP1155620A1 (fr) * | 2000-05-18 | 2001-11-21 | SportsCom Danmark ApS | Composition nutritive comme suppléments diététiques |
US7988960B2 (en) | 2000-06-20 | 2011-08-02 | Nestec S.A. | Probiotics in primary prevention of atopic diseases |
WO2001097822A1 (fr) * | 2000-06-20 | 2001-12-27 | Oy Aboatech Ab | Probiotiques pour la prevention primaire de maladies atopiques |
US7112322B2 (en) | 2000-06-20 | 2006-09-26 | Erika Isolauri | Probiotics in primary prevention of atopic diseases |
WO2002052954A3 (fr) * | 2001-01-08 | 2002-10-31 | Nestle Sa | Composition nutritionnelle destinee a une pathologie osseuse |
WO2002052954A2 (fr) * | 2001-01-08 | 2002-07-11 | Societe Des Produits Nestle S.A. | Composition nutritionnelle destinee a une pathologie osseuse |
EP1330957A2 (fr) * | 2002-01-15 | 2003-07-30 | Karl-Heinz Bauer | Supplement nutritive |
EP1330957A3 (fr) * | 2002-01-15 | 2003-10-22 | Karl-Heinz Bauer | Supplement nutritive |
JP2006523642A (ja) * | 2003-04-17 | 2006-10-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 妊娠女性用のマルチ−ビタミンおよびミネラル補助剤 |
WO2004091317A1 (fr) * | 2003-04-17 | 2004-10-28 | Boehringer Ingelheim International Gmbh | Supplement multivitamines/mineraux pour femmes enceintes |
WO2005013721A1 (fr) * | 2003-07-15 | 2005-02-17 | Nestec S.A. | Composition nutritionnelle liquide ou en poudre a forte teneur en fibres et en calories |
WO2005067737A1 (fr) * | 2003-12-29 | 2005-07-28 | Arandi Sarl | Complement alimentaire destine a combler les deficits nutritionnels |
FR2864426A1 (fr) * | 2003-12-29 | 2005-07-01 | Arandi | Complement alimentaire destine a combler les deficits nutritionnels |
US10426791B2 (en) | 2004-05-17 | 2019-10-01 | N.V. Nutricia | Synergism of GOS and polyfructose |
US9084433B2 (en) | 2004-06-06 | 2015-07-21 | N. V. Nutricia | Intestinal barrier integrity |
US10499676B2 (en) | 2004-06-06 | 2019-12-10 | N.V. Nutricia | Intestinal barrier integrity |
US20160073669A1 (en) * | 2004-06-06 | 2016-03-17 | N.V. Nutricia | Intestinal barrier integrity |
US11076623B2 (en) | 2004-06-22 | 2021-08-03 | N.V. Nutricia | Intestinal barrier integrity |
AU2005253898B2 (en) * | 2004-06-22 | 2010-02-18 | N. V. Nutricia | Improvement of barrier integrity in hiv patients with fatty acids |
WO2005122791A2 (fr) * | 2004-06-22 | 2005-12-29 | N.V. Nutricia | Amelioration de l'integrite de la barriere intestinale chez les patients atteints de vih |
WO2005122791A3 (fr) * | 2004-06-22 | 2006-04-13 | Nutricia Nv | Amelioration de l'integrite de la barriere intestinale chez les patients atteints de vih |
JP2007215498A (ja) * | 2006-02-17 | 2007-08-30 | Otsuka Pharmaceut Co Ltd | 妊婦用飲料 |
JP2009529574A (ja) * | 2006-03-10 | 2009-08-20 | エヌ.ブイ.・ヌートリシア | 誕生後に乳児に最良の始まりを与えるための難消化性糖類の使用 |
AU2012265617B2 (en) * | 2006-03-10 | 2016-02-25 | N.V. Nutricia | Use of non-digestable sacharides for giving an infant the best start after birth |
WO2007105945A3 (fr) * | 2006-03-10 | 2007-11-08 | Nutricia Nv | Utilisation de saccharides non digestibles pour assurer à un nouveau-né le meilleur départ dans la vie |
AU2007225549B2 (en) * | 2006-03-10 | 2012-09-27 | N.V. Nutricia | Use of non-digestable sacharides for giving an infant the best start after birth |
US9872869B2 (en) | 2006-03-10 | 2018-01-23 | N. V. Nutricia | Use of non-digestible saccharides for giving an infant the best start after birth |
GB2438157A (en) * | 2006-05-18 | 2007-11-21 | Emma Derbyshire | Fortified drink for pregnant or postpartum mothers |
US8454950B2 (en) * | 2006-05-23 | 2013-06-04 | Nestec S.A. | Maternal supplement |
US20120027738A1 (en) * | 2006-05-23 | 2012-02-02 | Nestec S.A. | Maternal supplement |
US8372442B2 (en) | 2008-06-19 | 2013-02-12 | N.V. Nutricia | Liquid nutritional composition for bariatric surgery patients |
WO2009153065A1 (fr) | 2008-06-19 | 2009-12-23 | N.V. Nutricia | Composition nutritionnelle pour patients de chirurgie bariatrique |
EP2403352B1 (fr) * | 2009-03-02 | 2017-03-15 | Roquette Freres | Poudre granulée contenant des protéines végétales et des fibres, leur procédé d'obtention et leurs utilisations |
EP2597958A1 (fr) | 2010-07-28 | 2013-06-05 | Dawn Foods B.V. | Agent de glaçage pour produits de boulangerie |
FR2963725A1 (fr) * | 2010-08-16 | 2012-02-17 | Holymark | Composition alimentaire pour prevenir et limiter la perte de masse musculaire, la perte de densite minerale osseuse et le declin cognitif, en particulier chez les personnes agees de 50 ans et plus |
CN102640934A (zh) * | 2011-02-18 | 2012-08-22 | 周大捷 | 制备含α-亚麻酸、卵磷脂、维生素E、可溶性膳食纤维素的营养粉的方法 |
WO2012136543A1 (fr) * | 2011-04-05 | 2012-10-11 | Nestec S.A. | Utilisation d'une composition de céréales hypoallergénique induisant une tolérance orale spécifique |
EP2508193A1 (fr) * | 2011-04-05 | 2012-10-10 | Nestec S.A. | Utilisation de composition de céréale hypoallergénique pour induire une tolérance orale spécifique |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8545896B2 (en) | 2011-09-29 | 2013-10-01 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
US11542537B2 (en) | 2012-05-22 | 2023-01-03 | Purecircle Sdn Bhd | High-purity steviol glycosides |
WO2014134053A1 (fr) * | 2013-02-26 | 2014-09-04 | Jiva Pharma, Inc. | Esters d'ascorbate d'acides gras oméga 3 |
US20160198748A1 (en) * | 2013-05-28 | 2016-07-14 | Purecircle Sdn Bhd | High-Purity Steviol Glycosides |
US11312984B2 (en) | 2013-05-28 | 2022-04-26 | Purecircle Sdn Bhd | High-purity steviol glycosides |
WO2015089009A1 (fr) * | 2013-12-09 | 2015-06-18 | Abbott Laboratories | Compositions nutritionnelles contenant une protéine de riz conjointement avec des protéines de pois et/ou pomme de terre |
US11259551B2 (en) | 2016-09-09 | 2022-03-01 | International Agriculture Group, LLC | Natural cocoa alternative and methods of producing same |
US11968992B2 (en) | 2016-09-09 | 2024-04-30 | International Agriculture Group, LLC | Yogurt product from high starch fruits |
US11206841B2 (en) | 2016-09-09 | 2021-12-28 | International Agriculture Group, LLC | Yogurt product from high starch fruits |
EP3323296A1 (fr) * | 2016-11-16 | 2018-05-23 | Maresol GmbH & Co. KG | Chocolat avec éléments nutritifs ajoutés et procédé de fabrication d'un chocolat |
WO2021005088A1 (fr) * | 2019-07-11 | 2021-01-14 | Société des Produits Nestlé S.A. | Compositions alimentaires pour la gestion du poids |
WO2021018878A1 (fr) * | 2019-07-31 | 2021-02-04 | Lactalis Puleva, S.L. | Produit laitier buvable pour femmes enceintes et allaitantes |
EP3771342A1 (fr) * | 2019-07-31 | 2021-02-03 | Lactalis Puleva, S.L. | Produit laitier buvable pour femmes enceintes et allaitantes |
CN114340409A (zh) * | 2019-09-05 | 2022-04-12 | 雀巢产品有限公司 | 用于哺乳女性的食物组合物 |
CN114340407A (zh) * | 2019-09-05 | 2022-04-12 | 雀巢产品有限公司 | 用于哺乳女性的食物组合物 |
CN114340406A (zh) * | 2019-09-05 | 2022-04-12 | 雀巢产品有限公司 | 用于哺乳女性的食物组合物 |
CN114945710B (zh) * | 2019-11-22 | 2024-01-30 | Asa-能源有限公司 | 用于产生气态氢和氧的电解反应系统 |
CN114945710A (zh) * | 2019-11-22 | 2022-08-26 | Asa-能源有限公司 | 用于产生气态氢和氧的电解反应系统 |
CN113133485A (zh) * | 2020-01-17 | 2021-07-20 | 沃正营养(北京)科技有限公司 | 一种乳母营养粉 |
CN111165812A (zh) * | 2020-03-31 | 2020-05-19 | 中国农业大学 | 一种基于豌豆蛋白的针对过敏人群的全营养配方食品 |
CN111480838A (zh) * | 2020-05-26 | 2020-08-04 | 辽宁康汇医学临床研究有限公司 | 一种哺乳期产妇用营养复合粉及其制备方法 |
CN113383821A (zh) * | 2021-05-20 | 2021-09-14 | 浙江核力欣健药业有限公司 | 一种产褥期妇女专用营养配方粉及其制备方法 |
CN115530381A (zh) * | 2022-08-17 | 2022-12-30 | 中南大学 | 预防产前抑郁症的蛋白粉及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
GB9808579D0 (en) | 1998-06-24 |
AU3709499A (en) | 1999-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999053777A1 (fr) | Complement nutritionnel pour femmes enceintes et allaitantes | |
EP1675480B1 (fr) | Composition nutritionnelle contre les effets secondaires de la chimiotherapie ou de la radiotherapie | |
JP4422726B2 (ja) | 満腹促進食品組成物 | |
US6576253B2 (en) | Food bars containing nutritional supplements | |
EP1737304B1 (fr) | Formule concentree liquide | |
CA2684929C (fr) | Complement liquide acidifie de lait maternel | |
EP1996031B1 (fr) | Formule pour prématurés | |
US20060088574A1 (en) | Nutritional supplements | |
US20130243904A1 (en) | Nutritional products having improved organoleptic properties | |
WO2002005667A2 (fr) | Ingredients mineraux ou de vitamine encapsules dans de l'oligosaccharide | |
US20160213040A1 (en) | Nutritional composition for pregnant women with a beneficial glucose and insulin profile | |
US20120201922A1 (en) | Liquid transition nutrition for infants | |
US20210106038A1 (en) | Nutritional composition | |
US20150025143A1 (en) | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance | |
EP2708146A1 (fr) | Composition nutritionnelle pour femmes enceintes avec un profil de glucose et d'insuline bénéfiques | |
CA2863286A1 (fr) | Utilisation de systemes glucidiques specifiques pendant la grossesse pour affecter la progeniture | |
Elvevoll et al. | The emerging importance of dietary lipids, quantity and quality, in the global disease burden: the potential of aquatic resources | |
US20160029679A1 (en) | Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women | |
CN116548606A (zh) | 适宜作为餐前负荷的缓升糖高饱腹感营养组合物及其应用 | |
CZ20021960A3 (cs) | Nutričně úplný nápoj pro léčbu syndromu krátkého střeva | |
Lloyd | US whey products and child nutrition | |
Carter et al. | Natural Product Trends | |
MXPA98005035A (en) | Composition and method for providing nutrition to diabeti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |